Top Markets
Coin of the day
Medivir AB (publ) Medivir AB (publ)

Medivir AB (publ)

MVIR-B
Rangering i aksjer #29654
Medivir AB (publ) is a pharmaceutical company established in 1987 and... Medivir AB (publ) is a pharmaceutical company established in 1987 and headquartered in Huddinge, Sweden. It is dedicated to the research, development, and global commercialization of medicines, with a primary focus on oncology. The company currently markets Zoviduo (formerly Xerclear) for the treatment of labial herpes. Its robust development pipeline includes Remetinostat, targeting MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818, aimed at liver cancer; and MIV-711, being advanced for osteoarthritis. Additionally, Medivir is progressing Birinapant and IGM-8444 for various solid tumor indications. Collaborative efforts are also key to its strategy, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS CoV-2, alongside licensing agreements with Tango Therapeutics for a preclinical research program and with Ubiquigent Limited for the USP7 preclinical research program.
Aksjekurs
$0.68377137
Sist synkronisert: 2023-05-23
Markedsverdi
$20.23M
Endring (1 dag)
-0.60%
Endring (1 år)
0.00%
Land
SE
Handel Medivir AB (publ) (MVIR-B)

Kategori

Aksjeprishistorikk for Medivir AB (publ) (MVIR-B)
Høyeste sluttskurs: $0.72 den 2023-05-01

Laveste sluttskurs: $13.34 den 2000-01-01
Aksjeprishistorikk for Medivir AB (publ) fra 2000 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -20.72%
2022 -17.55%
2021 16.81%
2020 -44.31%
2019 -43.10%
2018 -50.21%
2017 -38.87%
2016 22.76%
2015 -42.23%
2014 2.07%
2013 41.17%
2012 4.01%
2011 -52.79%
2010 87.56%
2009 95.64%
2008 -29.03%
2007 38.44%
2006 11.49%
2005 -57.32%
2004 13.36%
2003 186.51%
2002 -4.10%
2001 -61.41%
2000 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$527.89 35.09%
US
$996.61 51.72%
NL
$117.42 -19.34%
AU
$740.28 6.71%
CH
$1.07K -5.58%
KR